TC

Tek Chand Sharma

Director Director DIN 05157778
DIN 05157778 First appointment Dec 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Tek Chand Sharma

Data last updated:

Tek Chand Sharma was a Director at Raj Meditech Hospital Private Limited (2023–2025) and Director at Osm Infra Pvt. Ltd (from 2011). The companies operate in Healthcare.

DIN 05157778
Primary Designation Director
Industry Healthcare
First Appointment 29 Dec 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20232004Active
Osm Infra Pvt. Ltd U74900HR2011PTC043908
Director29 Dec 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Osm Infra Pvt. Ltd
Raj Meditech Hospital Private Limited
Premium access

Shareholding and investment profile for Tek Chand Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tek Chand Sharma

Tek Chand Sharma was first appointed on 29 Dec 2011 as Director at Osm Infra Pvt. Ltd. The most recent appointment on record is 25 Jul 2023 at Raj Meditech Hospital Private Limited.

Tek Chand Sharma held 2 earlier board appointments: Raj Meditech Hospital Private Limited (Director, 25 Jul 2023 to 22 Dec 2025); Osm Infra Pvt. Ltd (Director, from 29 Dec 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available